Latest news
Citizens raises AxoGen stock price target to $55 on strong growth - Investing.com UKInvesting.com UK · Fri, 31 Jul 2026 07:20:50 GMTAXGN Maintained by Canaccord Genuity -- Price Target Raised to $55 - GuruFocusGuruFocus · Thu, 30 Jul 2026 16:32:45 GMTAXGN Maintained by Citizens -- Price Target Raised to $55.00 - GuruFocusGuruFocus · Thu, 30 Jul 2026 15:50:19 GMTAnalysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Incyte (INCY) - theglobeandmail.comtheglobeandmail.com · Thu, 30 Jul 2026 14:10:00 GMT